Overlooked prophylaxis of Hepatitis B in patients undergoing hematopoietic stem cell transplantation

Abstract

This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as: Türe Z, KAlin-Unuvar G, Kahveci HN, Keklik M, Ulu-Kilic A. Overlooked prophylaxis of Hepatitis B in patients undergoing hematopoietic stem cell transplantation. Erciyes Med J 2020;

Successful Hematopoietic Stem Cell Transplantation from a Donor Sibling Infected with SARS-CoV-2 Using Molnupiravir Prophylaxis

“…Sufficient data on the transmission of SARS-CoV-2 to patients by blood products are not yet available. However, during the transplantation process, hepatitis B virus or cytomegalovirus prophylaxis is routinely applied and successful results are obtained [ 9 , 10 ]. It was thought that molnupiravir could prevent the development of infection in the recipient by suppressing viral replication.…”